These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 19426397)

  • 41. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.
    Lin CL; Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Jan; 14(1):64-9. PubMed ID: 17212646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
    Nagamatsu H; Itano S; Nagaoka S; Akiyoshi J; Matsugaki S; Kurogi J; Tajiri N; Yamasaki S; Koga H; Torimura T; Kumashiro R; Sata M
    Am J Gastroenterol; 2004 Dec; 99(12):2369-75. PubMed ID: 15571585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
    Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
    J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
    Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
    J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
    Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
    Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
    Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
    Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
    Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
    Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
    Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
    Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis.
    Kim JD; Choi JY; Bae SH; Yoon SK; Yang JM; Han NI; Choi SW; Lee CD; Lee YS; Jung ES
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):60-5. PubMed ID: 19804841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silent cirrhosis in hepatitis B virus related hepatocellular carcinoma.
    Singal AK
    Hepatogastroenterology; 2008; 55(86-87):1734-7. PubMed ID: 19102380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH; Park JW; Koh DW; Lee WJ; Kim CM
    Liver Int; 2009 Feb; 29(2):203-7. PubMed ID: 18662281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.